HOUSE_OVERSIGHT_024019.jpg

2.85 MB
View Original

Extraction Summary

1
People
3
Organizations
1
Locations
0
Events
0
Relationships
3
Quotes

Document Information

Type: Investment memorandum / fund strategy document
File Size: 2.85 MB
Summary

This document appears to be page 8 of a confidential investment memorandum for a fund identified as NLV-III (likely New Leaf Ventures III). It outlines the fund's investment strategy regarding Healthcare Information Technology (HIT), Medical Devices, and Biological Research Tools. The text discusses the impact of the HITECH Act and government funding on the market, arguing that regulatory challenges in medical devices will lead the fund to focus on later-stage opportunities, while highlighting the potential of smaller companies in HIT and research tools. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional investigation.

People (1)

Name Role Context
Fund Managers Managers of NLV-III
Outlining investment strategy and market views for the fund.

Organizations (3)

Name Type Context
NLV-III
The entity for which investment opportunities are being identified (likely New Leaf Ventures III).
U.S. Department of Health and Human Services
Source of actuarial estimate cited in footnote 13.
U.S. Government
Source of funding and legislative actions (HITECH Act).

Locations (1)

Location Context
The primary market for the healthcare technologies and investments discussed.

Key Quotes (3)

"The HITECH Act created a $25.9 billion Federal Government funded catalyst for the adoption of information technology in healthcare in the U.S."
Source
HOUSE_OVERSIGHT_024019.jpg
Quote #1
"The Fund Managers believe that smaller, focused companies will play a key role in developing and deploying information based products... and that a large number of these will be compelling investment opportunities for NLV-III."
Source
HOUSE_OVERSIGHT_024019.jpg
Quote #2
"NLV-III will have somewhat less exposure to this sector [Medical Devices] than previous funds."
Source
HOUSE_OVERSIGHT_024019.jpg
Quote #3

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document